Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Newstrike Brands Ltd NWKRF

Healthcare Biotechnology Cannabis
"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."


OTCPK:NWKRF - Post by User

Newstrike Brands Ltd > $2.15 is my target
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by SLCGrad2kon Jan 22, 2018 12:41pm
218 Views
Post# 27408843

RE:RE:RE:RE:RE:RE:$2.15 is my target

RE:RE:RE:RE:RE:RE:$2.15 is my target
the only clear thing is HIP is worth .033 of CMED shares.. but this is MJ and trading.. love it


Completely agree, its a nice ride but its going to come crashing down again especially if the friendly deal goes through.  ACB is going to buy CMED with HIP at HIP's original CMED offer.  CMED shareholders will be the main winners here.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities